These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11219276)

  • 21. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study.
    Wu KH; Tan AG; Rochtchina E; Favaloro EJ; Williams A; Mitchell P; Wang JJ
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1983-8. PubMed ID: 17460250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
    Torbus-Lisiecka B; Bukowska H; Jastrzebska M; Chelstowski K; Honczarenko K; Naruszewicz M
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():52-9. PubMed ID: 12063777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
    Godsland IF; Elkeles RS; Feher MD; Nugara F; Rubens MB; Richmond W; Khan M; Donovan J; Anyaoku V; Flather MD;
    Diabet Med; 2006 Nov; 23(11):1192-200. PubMed ID: 17054594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid and inflammatory markers for the prediction of coronary artery disease: a multi-marker approach.
    Bogavac-Stanojević N; Jelić-Ivanović Z; Spasojević-Kalimanovska V; Spasić S; Kalimanovska-Ostrić D
    Clin Biochem; 2007 Sep; 40(13-14):1000-6. PubMed ID: 17632095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A
    Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
    Gau G
    Mayo Clin Womens Healthsource; 2005 Jun; 9(6):S1-2. PubMed ID: 15888993
    [No Abstract]   [Full Text] [Related]  

  • 29. Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.
    Naruszewicz M; Klinke M; Dziewanowski K; Staniewicz A; Bukowska H
    Metabolism; 2001 Feb; 50(2):131-4. PubMed ID: 11229418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
    Cummings DM; King DE; Mainous AG; Geesey ME
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classical and "non-classical" cardiovascular risk factors in Tunisian patients with end stage renal disease: prevalence and association with cardiovascular events.
    Fellah H; Feki M; Feki H; Souissi M; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Lab; 2004; 50(7-8):447-53. PubMed ID: 15330514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein. Should it be considered a coronary risk factor?
    Aronow WS
    Geriatrics; 2003 May; 58(5):19-22, 25. PubMed ID: 12756677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel risk factors and markers for coronary disease.
    Ridker PM
    Adv Intern Med; 2000; 45():391-418. PubMed ID: 10635056
    [No Abstract]   [Full Text] [Related]  

  • 34. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration.
    Vine AK; Stader J; Branham K; Musch DC; Swaroop A
    Ophthalmology; 2005 Dec; 112(12):2076-80. PubMed ID: 16225921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J
    Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Emerging risk factors for cardiovascular disease].
    Demant T
    Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of risk factors for coronary heart disease in vascular medicine: long-term experience and a personal view from the laboratory.
    Demacker PN
    Semin Vasc Med; 2004 Feb; 4(1):23-9. PubMed ID: 15199430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of coronary artery disease in the Lebanese population.
    Abchee A; Puzantian H; Azar ST; Shbaklo H; Nasrallah A; Sawaya FJ; Alam S; Zalloua PA
    Thromb Res; 2006; 117(6):631-7. PubMed ID: 15985286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.
    Michalsen A; Lehmann N; Pithan C; Knoblauch NT; Moebus S; Kannenberg F; Binder L; Budde T; Dobos GJ
    Eur J Clin Nutr; 2006 Apr; 60(4):478-85. PubMed ID: 16306923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.